<p>The growth and/or survival of hvKP1 was assessed at 0, 3, 6, and 24 hours in 100% human ascites (batch 2) or M9 minimal medium at the starting inocula of approximately 10<sup>3</sup> cfu/ml, 10<sup>5</sup> cfu/ml, and 10<sup>7</sup> cfu/ml. <u>Panel A</u>: 100% human ascites, Panel B: 100% human ascites heated at 56°C for 30 minutes, and <u>Panel C:</u> M9 minimal medium. Data are Mean ± S.E.M.; N = 3.</p
<p><b>A</b>: Correlation analysis between VEGF concentrations and plasma glucose levels in the patie...
<p>(A) Western blot analysis of the plasma membrane and soluble fractions of the hKv1.5 protein isol...
<p>Mutant strain A2, the control (DH5α Δ<i>crp</i> harbouring plasmid pKCP containing native <i>crp<...
<p>The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2) supplemented...
<p>The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2). <u>Panel A<...
<p>The growth and/or survival of hvKP1 was assessed at 0, 3, 6, and 24 hours in 100% human ascites s...
<p>The growth of cKP1-4 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2) that was he...
<p>The survival of hvKP1 in 80% active or heat inactivated (56°C for 30 minutes (Δ56°C)) human serum...
<p>Animals were challenged subcutaneously with 3.15×10<sup>4</sup> cfu of hvKP1 grown in conditioned...
<p>The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2). <u>Panel A<...
<p>A: The concentration of HGF produced by non-labeled (normal) ASCs (1×10<sup>5</sup>) or ASCs labe...
<p>Growth curves were obtained for each population by haemocytometer cell counting (A), evaluation o...
<p>A. At the end of experiments, no obvious signs of ascites formation are seen in combination test ...
<p>The survival index was calculated with the equation described in the method. The survival index o...
<p>For L-J (0.1), biphasic medium (0.1), and MGIT (0.1), a mean 0.1 ml of inocula were incubated. Fo...
<p><b>A</b>: Correlation analysis between VEGF concentrations and plasma glucose levels in the patie...
<p>(A) Western blot analysis of the plasma membrane and soluble fractions of the hKv1.5 protein isol...
<p>Mutant strain A2, the control (DH5α Δ<i>crp</i> harbouring plasmid pKCP containing native <i>crp<...
<p>The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2) supplemented...
<p>The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2). <u>Panel A<...
<p>The growth and/or survival of hvKP1 was assessed at 0, 3, 6, and 24 hours in 100% human ascites s...
<p>The growth of cKP1-4 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2) that was he...
<p>The survival of hvKP1 in 80% active or heat inactivated (56°C for 30 minutes (Δ56°C)) human serum...
<p>Animals were challenged subcutaneously with 3.15×10<sup>4</sup> cfu of hvKP1 grown in conditioned...
<p>The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2). <u>Panel A<...
<p>A: The concentration of HGF produced by non-labeled (normal) ASCs (1×10<sup>5</sup>) or ASCs labe...
<p>Growth curves were obtained for each population by haemocytometer cell counting (A), evaluation o...
<p>A. At the end of experiments, no obvious signs of ascites formation are seen in combination test ...
<p>The survival index was calculated with the equation described in the method. The survival index o...
<p>For L-J (0.1), biphasic medium (0.1), and MGIT (0.1), a mean 0.1 ml of inocula were incubated. Fo...
<p><b>A</b>: Correlation analysis between VEGF concentrations and plasma glucose levels in the patie...
<p>(A) Western blot analysis of the plasma membrane and soluble fractions of the hKv1.5 protein isol...
<p>Mutant strain A2, the control (DH5α Δ<i>crp</i> harbouring plasmid pKCP containing native <i>crp<...